Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 2140 of 20,252 grants

Active NON-SBIR/STTR RPGS
Multicomponent mhealth interventions for healthcare providers and the community to increase cancer screening in India
NATIONAL CANCER INSTITUTE Implenomics Llcs United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT Given that a large proportion of cancers are detected at a late stage in India, approaches to increase screening uptake could have a significant impact on...

$3.29M
USD
Active SBIR-STTR RPGS
ConnectedNest: a digital platform connecting individuals with cancer to social care
NATIONAL CANCER INSTITUTE Xanthoshealth, Inc United States 2024 – 2026

SUMMARY ConnectedNest, a novel electronic social care referral platform developed by XanthosHealth, addresses the impact of social determinants of health (SDoH) on individuals faci...

$9.55M
USD
Active RESEARCH CENTERS
1/2 Howard - Hopkins Comprehensive Alliance in Cancer Research, Education, and Equity (H2CAREE)
NATIONAL CANCER INSTITUTE Howard University United States 2024 – 2029

PROJECT SUMMARY In response to NIH PAR-23-308, the Howard-Johns Hopkins Comprehensive Alliance in Cancer Research, Education and Equity (H2CAREE) initiative aims to advance cancer...

$13.27M
USD
Active RESEARCH CENTERS
2/2 Howard - Hopkins Comprehensive Alliance in Cancer Research, Education, and Equity (H2CAREE)
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2024 – 2029

PROJECT SUMMARY In response to NIH PAR-23-308, the Howard-Johns Hopkins Comprehensive Alliance in Cancer Research, Education and Equity (H2CAREE) initiative aims to advance cancer...

$13.44M
USD
Active NON-SBIR/STTR RPGS
Randomized Clinical Trial of a Culturally-Tailored Suite of Smoking Cessation Resources for American Indian Persons
NATIONAL CANCER INSTITUTE University of Minnesota United States 2024 – 2029

While American Indian (AI) persons have historically used wild or homegrown tobacco for spiritual purposes, the use of commercially produced tobacco has risen dramatically. Today,...

$6.13M
USD
Active NON-SBIR/STTR RPGS
Development of three KSHV vaccine platforms and chimeric MHV68-K-G for in vivo mouse infection study
NATIONAL CANCER INSTITUTE Cleveland Clinic Lerner Com-Cwru United States 2024 – 2029

Abstract Kaposi's sarcoma-associated herpesvirus (KSHV) is a prevalent virus that establishes a lifelong persistent infection in humans and is associated with Kaposi's sa...

$9.9M
USD
Active SBIR-STTR RPGS
NP855 for Targeting Thyrointegrin αvβ3 receptors and Norepinephrine Transporter in Neuroblastoma Management
NATIONAL CANCER INSTITUTE Nanopharmaceuticals, Llc United States 2024 – 2027

SUMMARY: Neuroblastoma (NB) is the most common cancer diagnosed in children younger than one year old and is the most frequent solid tumor in children < 5-years of age. Those wi...

$7.92M
USD
Completed SBIR-STTR RPGS
Development of a novel, RNA-interference-based therapeutic to treat prostate cancer
NATIONAL CANCER INSTITUTE Nuago Therapeutics Inc United States 2024 – 2025

PROJECT SUMMARY Prostate cancer (PC) is the most common cancer in men, and the second leading cause of cancer death among men in the United States. There is a critical unmet need t...

$4M
USD
Completed SBIR-STTR RPGS
Development of a Novel Nectin Targeting Antibody-drug Conjugate for Ovarian Cancer Therapy
NATIONAL CANCER INSTITUTE Resonant Therapeutics, Inc United States 2024 – 2025

PROJECT SUMMARY/ABSTRACT Ovarian cancer is the most lethal gynecologic cancer with limited therapeutic options. Targeted cancer therapeutics, such as antibody-drug conjugates (ADCs...

$3.71M
USD
Active NON-SBIR/STTR RPGS
Bioactivity of CAR T cells secreting T cell engager-anitbodies in humans with glioblastoma
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2024 – 2029

PROJECT SUMMARY Glioblastoma (GBM) is a deadly brain tumor with limited treatment options. We have developed a promising new treatment for GBM using chimeric antigen receptor (CAR)...

$6.53M
USD
Active NON-SBIR/STTR RPGS
Video Inspired Discussions about Ethical Outcomes in Pediatrics (VIDEO-PEDS)
NATIONAL CANCER INSTITUTE Dartmouth-Hitchcock Clinic United States 2024 – 2026

Parents of children with cancer often face complicated decision making throughout their child’s illness. Goals-of-care (GOC) interventions help patients, their families, and clinic...

$6.63M
USD
Active NON-SBIR/STTR RPGS
Pediatric acute lymphoblastic leukemia: Improving outcomes through incorporation of novel targeted therapies into treatment for relapsed and newly diagnosed disease
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2024 – 2029

O’Brien R50 Research Specialist (Clinician Scientist) Project Summary/Abstract While many children with acute lymphoblastic leukemia (ALL) are cured with frontline therapy, for tho...

$1.72M
USD
Active NON-SBIR/STTR RPGS
MetaboCore: Needle biopsy assay of drug sensitivity for solid tumors.
NATIONAL CANCER INSTITUTE University of Washington United States 2024 – 2029

Abstract The goal of personalized oncology is to select the most appropriate drug(s) for individual cancers. A number of platforms (e.g., organoids and PDX mice) have been develope...

$4.01M
USD
Active SBIR-STTR RPGS
Torch Recon: An Innovative Reconstruction Software for Increased Throughput and Improved Low-Count Quantitative SPECT Imaging
NATIONAL CANCER INSTITUTE Voximetry, Inc United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT Single-photon emission computed tomography (SPECT) imaging plays a pivotal role in radiopharmaceutical therapy (RPT), allowing clinicians to personalize pr...

$10.04M
USD
Active NON-SBIR/STTR RPGS
Steering the next generation of NCI-sponsored clinical trials in gastroesophageal cancers
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2024 – 2029

Gastrointestinal cancers, and gastroesophageal adenocarcinomas in particular, are experiencing a clinical renaissance with the approval of recent biomarker-directed therapies. With...

$789.5K
USD
Active NON-SBIR/STTR RPGS
Assay Development and Prognostic Model for Predicting Early Clinical Failure in Follicular Lymphoma
NATIONAL CANCER INSTITUTE University of Arizona United States 2024 – 2026

ABSTRACT Follicular lymphoma (FL) is the most common indolent non-Hodgkin lymphoma (NHL) subtype with a highly variable clinical course. While asymptomatic and low-tumor burden pat...

$2.07M
USD
Active NON-SBIR/STTR RPGS
Multimodal dendrimer theranostics targeting aggressive subtypes of prostate cancer
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2024 – 2029

PROJECT SUMMARY Our ultimate goal is to develop a practical, theranostic platform for managing PC. Prostate cancer (PC) is the second most common cancer and the fifth most frequent...

$6.92M
USD
Active NON-SBIR/STTR RPGS
State-transition and leukemia potential dynamics to inform disease evolution and adaptive therapy
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2024 – 2029

PROJECT SUMMARY Acute myeloid leukemia (AML) is a group of aggressive and highly heterogeneous malignancies with poor overall survival. Despite advances in identification of molecu...

$5.91M
USD
Active NON-SBIR/STTR RPGS
Impact of Rural Hospital Closures on Cancer Outcomes and Cancer Racial Disparity among Medicare Beneficiaries
NATIONAL CANCER INSTITUTE University of Texas Arlington United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT Since 2005, 199 rural hospitals have closed in the US. These closures have resulted in a loss of primary care physicians, surgical services, limited access...

$1.71M
USD
Active NON-SBIR/STTR RPGS
Understanding the biology of disparity-associated genomically stable gastric tumors
NATIONAL CANCER INSTITUTE University of California At Davis United States 2024 – 2026

PROJECT SUMMARY Gastric cancer (GC) has a high mortality rate in Latinos. This is likely the result of multi-level social determinants of health and population-specific factors. Ou...

$2.42M
USD